Triveni Bio

Drug DiscoveryWebsite
Current Valuation
$310.0M
As of June 18, 2025
Total Funding Raised
$231.6M
Across 2 rounds
Last Round
Later Stage VC

$115.0M

Last Funding
Jun 2025

Funding date

Capital Efficiency
1.34x

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
DateRoundAmountPost-ValuationGrowth
June 18, 2025Later Stage VC (Series B)$115.0MN/A-
October 26, 2023Early Stage VC (Series A)$91.6MN/A-
Valuation Analysis

Current Valuation Metrics

Triveni Bio is currently valued at $310.0M as of June 18, 2025. The company has raised a total of $231.6M in funding across 2 funding rounds.

Capital Efficiency

With a capital efficiency ratio of 1.34x, Triveni Bio has achieved a valuation that is 1.34 times the total capital raised.

Track Triveni Bio Valuation Updates

Get notified when Triveni Bio raises new funding or valuation changes

View 5 companies free

Create a free account to unlock Triveni Bio's valuation history, funding rounds, and growth metrics.

No credit card required

What is Triveni Bio Worth in 2026?

Triveni Bio is a leading private company in the Drug Discovery sector. Track Triveni Bio's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Triveni Bio Valuation is Determined

Private company valuations like Triveni Bio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.